23.24
price up icon5.25%   1.16
after-market アフターアワーズ: 23.24
loading
前日終値:
$22.08
開ける:
$22.38
24時間の取引高:
2.29M
Relative Volume:
1.24
時価総額:
$2.06B
収益:
$217.42M
当期純損益:
$-243.25M
株価収益率:
-8.3143
EPS:
-2.7952
ネットキャッシュフロー:
$-278.35M
1週間 パフォーマンス:
+6.31%
1か月 パフォーマンス:
+34.03%
6か月 パフォーマンス:
+5.11%
1年 パフォーマンス:
+166.21%
1日の値動き範囲:
Value
$22.04
$23.47
1週間の範囲:
Value
$20.70
$23.47
52週間の値動き範囲:
Value
$8.71
$25.59

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1094)
Name
電話
781-419-1400
Name
住所
730 THIRD AVENUE, NEW YORK, MA
Name
職員
298
Name
Twitter
@syndax
Name
次回の収益日
2026-08-03
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

Compare SNDX vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
SNDX icon
SNDX
Syndax Pharmaceuticals Inc
23.24 1.96B 217.42M -243.25M -278.35M -2.7952
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.93 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.50 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-16 再開されました H.C. Wainwright Buy
2025-09-10 再開されました Stifel Buy
2025-09-04 再開されました Guggenheim Buy
2025-08-05 繰り返されました BTIG Research Buy
2025-07-10 開始されました Goldman Buy
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
08:27 AM

Syndax Pharmaceuticals holds steady as investors await a fresh catalyst - AD HOC NEWS

08:27 AM
pulisher
Jul 06, 2026

SG Americas Securities LLC Has $900,000 Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jul 06, 2026
pulisher
Jul 01, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Jul 01, 2026
pulisher
Jul 01, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Draws Fresh Market Attention - Kalkine Media

Jul 01, 2026
pulisher
Jul 01, 2026

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jul 01, 2026
pulisher
Jun 30, 2026

Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates? - Insider Monkey

Jun 30, 2026
pulisher
Jun 30, 2026

Purchase/sale of business (net) of Syndax Pharmaceuticals Inc – SWB:1T3 - TradingView

Jun 30, 2026
pulisher
Jun 29, 2026

Price to sales forward of Syndax Pharmaceuticals Inc – MUN:1T3 - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to revenue forward of Syndax Pharmaceuticals, Inc. – NASDAQ:SNDX - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Does Syndax Pharmaceuticals’ (SNDX) Russell Value Index Exit Quietly Recast Its Liquidity And Risk Narrative? - simplywall.st

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to EBITDA forward of Syndax Pharmaceuticals, Inc. – NASDAQ:SNDX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Trading the Move, Not the Narrative: (SNDX) Edition - Stock Traders Daily

Jun 28, 2026
pulisher
Jun 28, 2026

Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Price to earnings forward of Syndax Pharmaceuticals, Inc. – NASDAQ:SNDX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Price to earnings forward of Syndax Pharmaceuticals Inc – DUS:1T3 - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of Syndax Pharmaceuticals Inc – DUS:1T3 - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Price to book forward of Syndax Pharmaceuticals, Inc. – NASDAQ:SNDX - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

Price to sales forward of Syndax Pharmaceuticals Inc – DUS:1T3 - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to book forward of Syndax Pharmaceuticals Inc – MUN:1T3 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Syndax Pharmaceuticals Inc Actuals & Estimates (DUS:1T3) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

SNDX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

H.C. Wainwright Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Jun 25, 2026
pulisher
Jun 25, 2026

1T3 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 23, 2026

Syndax Pharmaceuticals (SNDX) Stock Could Be 51.9% Undervalued After SAVE Trial Data - Sahm

Jun 23, 2026
pulisher
Jun 23, 2026

Syndax Pharmaceuticals Inc (SNDX) Institutional Confidence - TradingKey

Jun 23, 2026
pulisher
Jun 20, 2026

Syndax Pharmaceuticals (SNDX) TD Cowen 46th Annual Health Care Conference Summary - Quartr

Jun 20, 2026
pulisher
Jun 20, 2026

Syndax Pharmaceuticals StockLong-term cancer strategy under investor scrutiny - AD HOC NEWS

Jun 20, 2026
pulisher
Jun 20, 2026

Is Strong SAVE Trial Data Altering The Investment Case For Syndax Pharmaceuticals (SNDX)? - Sahm

Jun 20, 2026
pulisher
Jun 18, 2026

Elmind Capital LP Purchases New Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jun 18, 2026
pulisher
Jun 18, 2026

Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Catalio Capital Management LP - MarketBeat

Jun 18, 2026
pulisher
Jun 18, 2026

Eversept Partners LP Decreases Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jun 18, 2026
pulisher
Jun 18, 2026

Syndax Pharmaceuticals Inc (SNDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Syndax Pharmaceuticals Inc - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Apis Capital Advisors LLC Acquires 86,000 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jun 18, 2026
pulisher
Jun 18, 2026

Syndax Pharmaceuticals Inc (SNDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals stock gains test resistance near $19.68 after EHA congress participation - Traders Union

Jun 17, 2026
pulisher
Jun 17, 2026

(SNDX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jun 17, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals Inc (SNDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals Inc (SNDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals Inc (SNDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals Inc (SNDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Syndax Pharmaceuticals Inc (SNDX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 15, 2026

Syndax Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus

Jun 15, 2026
pulisher
Jun 15, 2026

Syndax Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus

Jun 15, 2026
pulisher
Jun 14, 2026

Eventide Asset Management LLC Has $26.01 Million Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jun 14, 2026
pulisher
Jun 14, 2026

Syndax Pharmaceuticals (SNDX) Stock Valuation After Positive SAVE Trial Data In High-Risk Leukemia - Sahm

Jun 14, 2026
pulisher
Jun 13, 2026

Syndax Pharmaceuticals (SNDX) Is Up 5.2% After Strong All-Oral Revuforj SAVE Trial DataWhat's Changed - Yahoo Finance

Jun 13, 2026
pulisher
Jun 13, 2026

Voss Capital LP Buys Shares of 125,000 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Jun 13, 2026

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Syndax Pharmaceuticals Inc (SNDX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Botwood Nicholas A.J.
Head of R&D, CMO
Jun 11 '26
Option Exercise
13.82
22,515
311,157
95,165
Botwood Nicholas A.J.
Head of R&D, CMO
Jun 11 '26
Sale
18.00
34,280
617,040
60,885
Botwood Nicholas A.J.
Head of R&D, CMO
Jun 12 '26
Sale
18.14
31,235
566,603
60,885
$112.86
price up icon 1.18%
$57.82
price up icon 1.58%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.91
price down icon 0.18%
$190.46
price up icon 0.25%
大文字化:     |  ボリューム (24 時間):